Advertisement BioClinica enters into agreement for Optimizer technology - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BioClinica enters into agreement for Optimizer technology

BioClinica, a provider of clinical trial management services, has entered into five-year enterprise-wide agreement with a pharmaceutical company for BioClinica Optimizer, to simulate and forecast clinical trial supply scenarios for their worldwide clinical trial operations.

BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, and clinical supply chain design and optimisation solutions

BioClinica eClinical division president Peter Benton said that progressive companies seek the best available tools to design and support the complex logistics associated with global clinical trials. Six of the Top 10 pharmaceutical and biotech companies now use BioClinica Optimizer technology, with savings measured in millions of dollars.

BioClinica CEO Mark Weinstein said that this selection exemplifies client validation of eClinical strategy and this organisation was already a large imaging services client; now BioClinica will support new areas of their clinical trial processes.

"The client told us that with BioClinica Optimizer they anticipate better information for designing studies with faster study starts, a reduction in patient participation drop-off, reduced waste and overstocking and an overall cost savings with improved supply management. This is a win for both organizations," Weinstein said.